Immunotherapy: an innovative and efficient tool in the battle against haematological tumours
In recent years, one of the strategies developed in the field of haematology is the modification of the patient’s immune system, also known as ‘immun1
In recent years, one of the strategies developed in the field of haematology is the modification of the patient’s immune system, also known as ‘immun1
Today the results of the phase 2 CORALLEEN clinical trial, promoted by the international academic group SOLTI, have been presented. The study, publis1
Researchers at IDIBAPS, CIBERehd and ICFO implement gold nanoparticles and plasmonics to treat liver fibrosis in mice.
Despite the enormous progress made in the treatment of HIV, the spread of HIV remains uncontrolled around the world. The number of new infections has1
There are indications that intermittent fasting could help with weight loss. Although still in the preliminary stages, studies show that this practic1
A study coordinated by researchers of the Clínic-IDIBAPS and published in The Lancet Gastroenterology & Hepatology establishes the safe dose of simva1
Researchers from the IDIBAPS and the Institute of Neurosciences of the University of Barcelona (UBNeuro) described a mechanism, the increase of prote1
Studies carried out in the 1990s showed that controlling glucose levels through multiple doses of insulin reduced the risk of complications, but incr1
Researchers of the Hospital Clínic-IDIBAPS and the Josep Carreras Leukemia Research Institute have developed a new technique that allows detecting an1
The flu outbreak, which will inevitably come, will begin around the end of the year, and is set to last for 12-14 weeks. Flu can have notable affects1